Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

CEP 33779

Base Information Edit
CEP 33779

Synonyms:[8-(4-Methylsulfonylphenyl)[1,2,4]triazolo[1,5-a]pyridin-2-yl][3-(4-methylpiperazin-1-yl)phenyl]amine;

Suppliers and Price of CEP 33779
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • CEP-33779
  • 500μg
  • $ 55.00
  • DC Chemicals
  • CEP33779 >98%
  • 1 g
  • $ 2000.00
  • Crysdot
  • CEP-33779 98+%
  • 10mg
  • $ 226.00
  • Crysdot
  • CEP-33779 98+%
  • 100mg
  • $ 1128.00
  • Crysdot
  • CEP-33779 98+%
  • 50mg
  • $ 779.00
  • ChemScene
  • CEP-33779 99.36%
  • 50mg
  • $ 750.00
  • ChemScene
  • CEP-33779 99.36%
  • 100mg
  • $ 750.00
  • ChemScene
  • CEP-33779 99.36%
  • 10mg
  • $ 180.00
  • ChemScene
  • CEP-33779 99.36%
  • 5mg
  • $ 110.00
  • Cayman Chemical
  • CEP-33779 ≥95%
  • 1mg
  • $ 88.00
Total 25 raw suppliers
Chemical Property of CEP 33779 Edit
Chemical Property:
  • PKA:7.78±0.42(Predicted) 
  • PSA:94.45000 
  • Density:1.35 
  • LogP:3.80080 
  • Solubility.:≥23.15 mg/mL in DMSO with gentle warming; insoluble in EtOH 
Purity/Quality:

99% min *data from raw suppliers

CEP-33779 *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Description Janus kinases (JAKs) are non-receptor kinases that mediate signaling through cytokine receptors, often to members of the signal transducer and activator of transcription family. CEP-33779 is a potent, orally available inhibitor of JAK2 (IC50 = 1.3 nM). It shows 65-fold selectivity for JAK2 over JAK3. In mouse models of systemic lupus erythematosus, CEP-33779 reduces the production of inflammatory cytokines, decreases splenomegaly and lymphomegaly, and extends survival. It also diminishes inflammatory signaling and improves clinical scores in mice during collagen antibody-induced arthritis and collagen type II-induced arthritis. CEP-33779 induces regression of established colorectal tumors in mice, reducing angiogenesis and proliferation of tumor cells.
  • Uses CEP-33779 acts as an orally available inhibitor of JAK2 reducing the production of inflammatory cytokines and decreasing splenomegaly. Anti-arthritic agent. Anticancer agent.
Technology Process of CEP 33779

There total 11 articles about CEP 33779 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With dicyclohexyl-({2-[2-(dicyclohexylphosphanyl)phenyl]-phenyl})-phosphane; palladium diacetate; caesium carbonate; In 1,4-dioxane; at 100 ℃; for 72h; Inert atmosphere;
DOI:10.1021/jm300248q
Guidance literature:
Multi-step reaction with 3 steps
1.1: 1,4-dioxane / 18 h / Inert atmosphere
1.2: 20 h / 20 - 60 °C / Inert atmosphere
2.1: palladium diacetate; sodium carbonate; triphenylphosphine / 1,4-dioxane; water / 80 °C
3.1: dicyclohexyl-({2-[2-(dicyclohexylphosphanyl)phenyl]-phenyl})-phosphane; palladium diacetate; caesium carbonate / 1,4-dioxane / 72 h / 100 °C / Inert atmosphere
With dicyclohexyl-({2-[2-(dicyclohexylphosphanyl)phenyl]-phenyl})-phosphane; palladium diacetate; sodium carbonate; caesium carbonate; triphenylphosphine; In 1,4-dioxane; water; 2.1: Suzuki coupling / 3.1: Buchwald-Hartwig coupling;
DOI:10.1021/jm300248q
Refernces Edit
Post RFQ for Price